Subcutaneous vaccination with inactivated whole particles of Vac-3 induced anti-HA neutralization antibody against H5N1 HPAIVs after challenge infection and anti-NA antibody with neuraminidase inhibition activity against Vac-3 and pandemic (H1N1) 2009 virus. The gene discussed is XK; the disease is infection.